Top asthma drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

This statistic represents the top asthma drugs in the United States, based on revenue between July 2011 and June 2012. In this period, the asthma drug Singulair generated around 4.9 billion U.S. dollars of revenues.

Download this statistic as XLS, PNG and PDF?
Basic Account
  • Access to basic statistics (approx. 7%)
  • Common download functions
Premium Account
$588per year*
  • All the advantages of the Basic Account
  • Instant access to all statistics
  • Download as XLS, PNG and PDF
 Revenue in million U.S. dollars
Singulair 4,940.6
Advair Diskus 4,559.6
Spiriva Handihaler 2,588.8
Combivent 1,131.6
Symbicort 1,131.5
Proair HFA 1,035.5
Flovent HFA 975.4
Budesonide 923.2
Ventolin HFA 655.6
Xolair 591
Source information for logged in users only.
Show our solutions
Everything you need to know about...
Asthma - Statista Dossier
  • Great time-saver
  • All relevant statistics included

Offer: Order your Premium Account now & and get this dossier for free.

Get free dossier
You may also be interested in...
Show more
Market Analytics
Recent Statistics
Related market forecasts
Recommended studies and dossiers

Find the proper statistic fast and easy: